AI-Doctor’s accuracy in retinal disease detection redefines medical diagnosis

An advanced artificial Intelligence (AI) system designed to interpret fundus fluorescein angiography (FFA) images precisely.

Roche’s Spark loses CEO to RNA upstart; Ex-Elevation Oncology chief takes over at Affimed

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 7, 2024

Optimi Health & ATMA Receive No Objection Letter from Health Canada for Phase 2 Clinical Trial | Psychedelic Invest

Vancouver, British Columbia–(Newsfile Corp. – August 28, 2024) – Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) (“Optimi” or the “Company“), a GMP-compliant, Health

August 28, 2024

Totus Medicines closes $66M Series B to fund early-stage PI3Ka inhibitor, names new CEO

Small molecule biotech Totus Medicines has closed a $66 million Series B to carry its PI3Kα inhibitor through Phase Ia and has named Nassim Usman

December 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.